Business · 03/02/2011Updated: 10/17/2026 · 1 min read
FDA to Hold Public Meeting on Positron Emission Tomography Drug Applications
Summary
The FDA is hosting a public meeting to help producers of positron emission tomography (PET) drugs prepare for the December 12, 2011, deadline to submit applications for marketing approval, and to discuss the drug approval process and FDA's inspection procedures.
Original source language: Federal Register — Health and Human ServicesOpen original release →